Ketamine Therapy and Insurance: How to Get Reimbursed

Can You Get Reimbursed for Ketamine Therapy?

Yes, you can often get reimbursed for ketamine therapy, though the process works differently than standard direct insurance coverage. Insurance coverage means the insurer pays the provider directly. Out-of-network reimbursement means you pay upfront and submit a claim for partial repayment.

Most ketamine providers, including in-office infusion centers and at-home telehealth programs, operate outside traditional insurance networks. If your health plan includes out-of-network mental health benefits, you can submit documentation after paying to receive a portion of your money back.

Your exact reimbursement percentage depends on your plan's coinsurance rate and allowed amounts, a detail worth checking, since many people assume ketamine therapy is entirely out-of-pocket without ever calling member services. Checking your benefits takes just one phone call to member services.

Even partial reimbursement reduces the effective cost per session. Every dollar you submit also counts toward your annual deductible, accelerating the point at which your plan covers a higher share of all out-of-network care. When you call your insurance provider, ask these specific questions:

• Do I have out-of-network mental health benefits? Asking confirms if your plan allows out-of-network claims.
• What is my out-of-network deductible? You'll need to pay this amount before the plan begins covering costs.
• What is my coinsurance rate after the deductible? Once your deductible is met, this percentage determines how much the plan pays.

Why Reimbursement for Ketamine Therapy Is Complicated

The reimbursement landscape for ketamine therapy is fragmented because different forms of the medicine have different FDA approval statuses and billing pathways. There is no single universal coverage policy that applies to all patients. Insurers evaluate claims based on the medication prescribed, the setting where it is administered, and the patient's diagnosis.

Several factors create complexity for patients seeking coverage. Understanding these factors helps clarify why direct billing is rare and out-of-network claims are common.

• FDA approval status: Only one ketamine product (Spravato esketamine nasal spray) has FDA approval specifically for treatment-resistant depression. All other ketamine formulations used for mental health are prescribed off-label. Insurers often use FDA approval status as a gatekeeping criterion for direct coverage. Ketamine has been FDA-approved as an anesthetic since 1970 and has been on the WHO List of Essential Medicines since 1985.¹Off-label prescribing for mental health conditions is a standard and legally accepted medical practice.² A substantial percentage of psychiatric prescriptions are written off-label.³
• Site of care: Insurance plans often distinguish between in-office administration and at-home treatment. In-office settings may allow providers to bill for facility and monitoring codes. At-home programs typically fall outside traditional billing structures, pushing patients toward out-of-network reimbursement.
• Prior authorization and medical necessity: Insurers frequently require prior authorization and documented treatment history for Spravato. For off-label ketamine, these requirements are even less standardized and can vary widely.
• Plan design variation: Coverage rules vary dramatically between employer-sponsored plans, marketplace plans, Medicare, and Medicaid. Two people with the exact same insurer can experience different reimbursement outcomes based on their plan design.

While the complexity is real, it is entirely navigable. The following sections break down which treatments are most likely to be reimbursed and exactly how to submit your claims.

Which Ketamine Treatments Insurance Reimburses Most Often?

Reimbursement likelihood varies significantly by the type of ketamine treatment you receive. Below is a breakdown of how insurance handles the most common treatment modalities.

Is Spravato Covered by Insurance?

Spravato is an FDA-approved esketamine nasal spray administered in a certified healthcare setting under a strict REMS program. It is the only ketamine-derived product with FDA approval for treatment-resistant depression and major depressive disorder with suicidal ideation.⁷

Because Spravato has FDA approval, many commercial insurance plans cover it directly. Direct coverage typically comes with significant requirements, including prior authorization, documented failure of two or more antidepressants, and in-office administration with post-dose monitoring. Copays and coinsurance still apply and can be substantial, though some patients qualify for the Spravato withMe savings program to offset costs.

FDA approval makes Spravato the most straightforward path to direct insurance coverage. However, the REMS requirements create access and scheduling constraints that do not apply to other ketamine formats.

Are IV Ketamine Infusions Covered by Insurance?

IV ketamine infusions involve generic ketamine administered intravenously in a specialized setting. Sessions typically last 40 to 60 minutes. IV infusions are prescribed off-label for mental health conditions like depression and anxiety.

Most insurance plans do not directly cover IV ketamine because of its off-label status. Some centers can bill for associated services like psychiatric evaluations or monitoring using standard medical codes. You can also submit superbills for out-of-network reimbursement, though rates vary widely by plan and are typically partial.

IV ketamine centers typically charge $400–$800 per infusion. A standard initial course of six sessions can total $2,400–$4,800 or more. Out-of-network reimbursement can meaningfully offset these costs, but you should always confirm your benefits before starting.

Can At-Home Compounded Ketamine Be Reimbursed by Insurance?

At-home ketamine therapy uses sublingual tablets or other formulations prescribed by a licensed provider and compounded by a pharmacy. You self-administer the medicine at home under medical oversight. A peer treatment monitor is required to be present during every session at providers like Mindbloom.

At-home ketamine providers generally operate outside insurance networks, making direct billing uncommon. Patients with out-of-network mental health benefits can request an itemized statement or superbill from their provider.

You can then submit the superbill to your insurer for reimbursement. The provider consultation, evaluation, and treatment management components are the services most likely to be partially reimbursed.

At-home ketamine therapy is typically more affordable per session than IV infusions. Mindbloom's programs are approximately 60% less expensive than in-office IV ketamine. Combined with partial out-of-network reimbursement and HSA or FSA eligibility, the effective out-of-pocket cost can be much lower than many patients expect.

How Much Ketamine Therapy Costs and What Reimbursement Changes

Ketamine therapy costs vary widely depending on the treatment type and the specific provider. Understanding the realistic price ranges helps you evaluate what reimbursement actually means in practical terms.

Spravato copays vary by plan, and without savings programs, out-of-pocket costs can reach hundreds of dollars per session even with coverage. IV ketamine infusions typically cost several hundred dollars per session, meaning an initial course can total thousands of dollars. At-home ketamine therapy is generally the most accessible option.

Mindbloom offers programs of 6, 12, or 18 sessions. After you select a program, a licensed provider conducts a comprehensive medical evaluation to determine whether treatment is medically appropriate and to personalize your care plan. Mindbloom's at-home ketamine therapy ranges from $165 to $215 per session for new clients, depending on program length. A 6-session program is billed in monthly installments of $430 per month for three months.

Returning clients pay as little as $129 per session with an 18-session program. Reimbursement changes the financial picture in several important ways. Filing claims provides benefits beyond just getting a check in the mail.

• Partial reimbursement: Receiving a percentage of your payment back reduces the effective per-session cost directly.
• Deductible credit: Every dollar you submit counts toward your annual deductible. Once your deductible is met, your plan begins covering a higher percentage of all subsequent out-of-network care.
• Out-of-pocket maximum: Submitting claims moves you closer to your plan's annual out-of-pocket maximum. Once reached, the plan covers all remaining eligible costs at 100 percent.
• HSA and FSA stacking: You can pay for ketamine therapy with pre-tax dollars through an HSA or FSA and also submit for out-of-network reimbursement. Both financial mechanisms work simultaneously.

Many people who are eligible for partial reimbursement never submit their claims. They often assume the process is not worth the effort or do not realize the deductible credit benefit. Filing early in the plan year maximizes the downstream financial benefit across all your healthcare spending.

Step-by-Step: How to Submit for Out-of-Network Reimbursement

You can complete the entire reimbursement process in three steps.

Step 1: Confirm Out-of-Network Benefits for Mental Health Care

Call the member services number on the back of your insurance card. Ask about out-of-network benefits for outpatient mental health services. Some plans, particularly HMOs, do not include out-of-network benefits, while PPO and POS plans are more likely to include them.

Key questions to ask your representative include:

• Do I have out-of-network mental health benefits?
• What is my out-of-network deductible, and how much have I met this year?
• What is my out-of-network coinsurance rate?
• Is there a separate allowed amount or fee schedule for out-of-network claims?
• What is my out-of-pocket maximum for out-of-network services?

Step 2: Request an Itemized Statement and Supporting Documentation

After completing your sessions, request an itemized statement or superbill from your ketamine provider. The document contains all the necessary medical coding for your insurer. Some providers generate superbills automatically, while others provide them upon request.

Mindbloom provides documentation to support out-of-network reimbursement submissions.

Step 3: Submit the Claim and Track the Reimbursement Decision

Send the superbill and any required claim forms to your insurer. Most plans accept claims online through a member portal, by mail, or by fax. After submission, expect a processing period of a few weeks.

You will eventually receive an Explanation of Benefits detailing what was reimbursed and what was applied to your deductible.

Superbill and Billing Codes for Ketamine Therapy

Think of a superbill as an itemized receipt containing the medical and billing information insurers need to process an out-of-network reimbursement claim. No other document matters more in the reimbursement process.

A standard ketamine therapy superbill includes several specific pieces of information. Insurers require these details to verify the medical necessity and scope of the treatment.

• Provider information: The physician's name, credentials, NPI number, and tax ID.
• Patient information: Your name, date of birth, and insurance ID number.
• Service details: The dates of service, CPT codes for the services rendered, and the corresponding ICD-10 diagnosis codes.
• Charges: The exact amount paid for each specific service line.

CPT codes describe what specific service was provided, such as evaluation and management codes for provider consultations. ICD-10 codes describe the diagnosis being treated, such as major depressive disorder or generalized anxiety disorder. The codes used will vary by provider and the exact services included in your treatment plan.

Requesting and submitting a superbill is the single highest-impact step you can take to reduce your total program cost. Even a partial return, combined with deductible credit, can meaningfully reduce the total cost of a treatment program.

What to Do If Insurance Denies Your Claim

Insurance denials for ketamine therapy can often be appealed successfully when supported by clear medical documentation. If your insurer declines to reimburse a claim, you have the right to file a formal appeal.

An initial denial response is common for off-label treatments, which is exactly why the formal appeal pathway exists.

Option 1: File an Appeal with Additional Medical Documentation

You can request the exact reason for denial from your insurer, which will be listed on your Explanation of Benefits. Common reasons include "not medically necessary" or "not a covered benefit." Your prescribing provider can submit a letter of medical necessity with supporting documentation.

The documentation outlines your diagnosis, treatment history, and the rationale for ketamine therapy.

Option 2: Ask Your Employer or Broker About Plan Exceptions

If you have an employer-sponsored plan, your human resources department or benefits broker may be able to request a plan exception. They can sometimes secure a single-case agreement for your care. Self-funded employer plans have more flexibility to approve coverage for specific treatments.

Utilizing an underused pathway like this can result in direct coverage or improved reimbursement terms. Denials are simply part of the process, not the end of it. Between formal appeals, employer advocacy, and alternative payment mechanisms like HSA accounts, most people have more options than they initially realize.

How Structured Clinical Protocols Support Safe, Effective At-Home Ketamine Therapy

The safety and effectiveness of at-home ketamine therapy depend on the care framework surrounding it: rigorous screening, responsible prescribing, session protocols, ongoing monitoring, and integration support.

In supervised, sub-anesthetic ketamine care, abuse and dependence risk appears lower than in nonmedical or frequent unsupervised use because dosing is intermittent, individuals are screened, and treatment occurs within a monitored clinical plan.⁸ Ketamine is a Schedule III controlled substance, and medical programs utilize strict safeguards to prevent misuse. A protocol-driven care framework is designed to support patient safety and is associated with better therapeutic outcomes.

Following a defined treatment framework also generates the medical documentation necessary for reimbursement eligibility.

• Medical screening and eligibility: The comprehensive evaluation described earlier, covering medical history, psychiatric history, and current medications, is the foundation of safe prescribing.
• Clinician oversight and dosing: Providers use sub-anesthetic, therapeutic dosingwith ongoing adjustments based on patient response. Treatment frequency is personalized based on individual needs and medical guidance.
• Peer treatment monitor requirement: As noted earlier, a monitor must be present during every session, providing an additional layer of safety.
• Integration support: Guide coaching sessions, Group Integration Circles, and app-based programs help patients process their experiences.

Mindbloom is a specific, evidence-backed implementation of this framework. Mindbloom has facilitated over 700,000 supervised sessions and published two of the largest peer-reviewed, real-world outcomes studies of at-home ketamine therapy.^5,6 These studies were conducted on Mindbloom clients using the Mindbloom protocol.

In a peer-reviewed study of 11,441 patients, 89% of participants reported improvement in their symptoms, and 56.4% met criteria for response.⁶ Mindbloom is also the only at-home ketamine provider offering subcutaneous administration in addition to sublingual tablets.

Protocol-driven care is what makes at-home ketamine therapy both medically rigorous and reimbursement-eligible. Documentation from a defined treatment framework strengthens superbill filings and formal appeals.

Conclusion

Reimbursement for ketamine therapy is available to many people through out-of-network benefits, HSA accounts, and the deductible credit mechanism. The process requires checking your specific plan, requesting a superbill from your provider, and submitting a formal claim. Even partial reimbursement reduces your overall cost and moves you closer to your out-of-pocket maximum. If your claim is denied, appeals and employer-plan exceptions are viable next steps.

Important Safety Information

Ketamine is not FDA-approved for PTSD, depression, or anxiety. Common side effects include dissociation, increased blood pressure, nausea, dizziness, and cognitive impairment. Ketamine has abuse potential and is not appropriate for patients with uncontrolled hypertension, psychotic disorders, or substance use disorders. Do not drive or operate machinery until the day after treatment. Individual results may vary. Full safety information: www.mindbloom.com/safety-information

Off-Label Use Disclosure

Ketamine is FDA-approved only as an anesthetic. Use for mental health conditions represents off-label prescribing by licensed clinicians based on clinical judgment. Schedule III Controlled Substance - DEA regulations apply.